In the last weeks the unit of neuromuscular diseases in the Sant Pau Hospital, has published two scientific papers in the journal “Neurology”. The publications respond to three of the research lines developed by the unit
26
Sep
2019
Resonance
28
May
2018
28
May
2018
The Neuromuscular diseases Unit of Hospital Sant Pau publishes an article in the Brain Journal.
The doctors Xavier Suárez-Calvet, Eduard Gallardo and Isabel Illa of the Sant Pau Neuromuscular Unit, signed the paper entitled “JAK inhibitor improves type I interferon induced damage: proof of concept in dermatomyositis” published in the prestigious Brain Journal. This international collaboration study establishes the bases for the treatment with Ruxolitinib of patients with dermatomyositis resistant to conventional therapies. Ruxolitinib is an inhibitor of JAK1 / 2 which is a key molecule in the type I interferon signaling.
23
Oct
2017
23
Oct
2017
The pre-doctoral students Patricia Piñol and Alicia Alonso have been awarded for their work exhibited during the congress.